Mather Group, Llc. Laboratory Corp Of America Holdings Transaction History

Mather Group, Llc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 08, 2024	BUY	$192.5 - $216.35 $962 - $1,081	5 Added 0.8%	631 $128,000
Q1 2024 Apr 08, 2024	BUY	$209.01 - $232.56 $130,840 - $145,582	626 New	626 $136,000
Q2 2023 Aug 08, 2023	BUY	$211.93 - $241.33 $185,438 - $211,163	875 New	875 $211,000
Q1 2022 May 13, 2022	SELL	$259.82 - $298.18 $169,142 - $194,115	-651 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$271.6 - $314.21 $176,811 - $204,550	651 New	651 $204,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

Stay updated on Mather Group, Llc. with notifications on news.